Scibase Holding AB is a medical technology company specializing in the development and commercialization of diagnostic solutions for skin-related conditions. The company is renowned for its innovative product, Nevisense, which is an advanced tool designed for the non-invasive detection of melanoma, a type of skin cancer. By employing electrical impedance spectroscopy (EIS) technology, Nevisense evaluates the cellular composition and structure of skin lesions, enabling dermatologists to make informed decisions about potential malignancies. Scibase Holding AB significantly impacts the healthcare sector, particularly in dermatology, by providing tools that enhance early detection accuracy and improve patient outcomes. The company's technology supports medical professionals in clinics and hospitals globally, aligning with efforts to advance preventative medicine and reduce cancer-related mortalities. Based in Sweden, Scibase Holding AB continues to contribute to the medical diagnostic landscape with its cutting-edge research and development in skin health technologies.